<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">PAR</journal-id><journal-title-group><journal-title>Proceedings of Anticancer Research</journal-title></journal-title-group><issn>2208-3545</issn><eissn>2208-3553</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/par.v6i3.3884</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>A Summary of Lei Genping’s Experience in the Treatment of Chronic Nephritis</title><url>https://artdesignp.com/journal/PAR/6/3/10.26689/par.v6i3.3884</url><author>ZhangYue,LeiGenping</author><pub-date pub-type="publication-year"><year>2022</year></pub-date><volume>6</volume><issue>3</issue><history><date date-type="pub"><published-time>2022-05-30</published-time></date></history><abstract>Chronic glomerulonephritis involves multiple organs. It has a variety of clinical manifestations and is the major cause of progression to end-stage renal disease in patients with kidney disease. Professor Lei Genping believes that the treatment of this disease in Chinese medicine should be based on the deficiency and reality characteristics of the disease mechanism, distinguishing the priorities and identifying the strengths and weaknesses of the internal organs, as well as advocating the integration of Chinese and western medicine at the right time and in the right manner, in order to achieve fundamental results.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Allen PJ, Chadban SJ, Craig JC, et al., 2017, Recurrent Glomerulonephritis After Kidney Transplantation: Risk Factors and Allograft Outcomes. Kidney Int, 92(2): 461-469. DOI: 10.1016/j.kint.2017.03.015</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Moriyama T, 2019, Clinical and Histological Features and Therapeutic Strategies for IgA Nephropathy. Clin Exp Nephrol, 23(9): 1089-1099. DOI: 10.1007/s10157-019-01735-4</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Zhang WJ, Wang WG, Liang YJ, et al., 2015, Clinical Features and Treatment Status of Patients with End-Stage Renal Disease in Gansu Province. Chinese Journal of Kidney Disease, 31(8): 567-571.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Chen C, Shao S, Liu ZH, 2019, Effect of Tonifying Zhong Yi Qi Tang on Microinflammatory Status and TLRs/MYD88 Signaling Pathway in Patients with Chronic Nephritis. Zhejiang Journal of Integrative Medicine, 29(9): 726-729.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Rajasekaran A, Julian BA, Rizk DV, 2021, IgA Nephropathy: An Interesting Autoimmune Kidney Disease. Am J Med Sci, 361(2): 176-194. DOI: 10.1016/j.amjms.2020.10.003</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Becker M, Gnirck AC, Turner JE, 2020, Innate Lymphoid Cells in Renal Inflammation. Front Immunol, 11: 72. DOI: 10.3389/fimmu.2020.00072</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Wang H, (ed) 1997, Nephrology, 2nd Edition, Beijing People’s Health Press, Beijing, 409.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Liakos CI, Vyssoulis GP, Markou MI, et al., 2016, Twenty-Four-Hour Urine ?1-Microglobulin as A Marker of Hypertension-Induced Renal Impairment and Its Response on Different Blood Pressure-Lowering Drugs. J Clin Hypertens (Greenwich), 18(10): 1000-1006. DOI: 10.1111/jch.12811</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Chen Y, 2007, Advances in Nephroprotective Effects of ACEI and ARB. China Journal of Medicine, 2007(02): 122-124, 121.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Cheng H, Chen YP, 2002, Rational Application of Angiotensin-Converting Enzyme Inhibitors in the Treatment of Renal Disease. China Journal of Medicine, 2002(04): 279-280.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Chen Y, 2005, Treatment Goals and Drug Applications for Hypertension in Chronic Kidney Disease. Journal of Clinical Internal Medicine, 2005(11): 10-12.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Zhang L, Li Y, 2015, Treatment of Renal Proteinuria from the Three Organs of the Lung, Spleen and Kidney. Sichuan Traditional Chinese Medicine, 33(1): 43-45.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Li N, Xu Z-C, 2014, Professor Xu Zaichun’s Experience in Treating Proteinuria in Chronic Glomerulonephritis Experience. Journal of Shaanxi College of Traditional Chinese Medicine, 37(3): 18-19.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Domenech P, Perez T, Saldarini A, et al., 2017, Kidney-Lung Pathophysiological Crosstalk: Its Characteristics and Importance. Int Urol Nephrol, 49(7): 1211-1215. DOI: 10.1007/s11255-017-1585-z</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Lewis SM, Williams A, Eisenbarth SC, 2019, Structure and Function of the Immune System in the Spleen. Sci Immunol, 4(33): eaau6085. DOI: 10.1126/sciimmunol.aau6085</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B16" content-type="article"><label>16</label><element-citation publication-type="journal"><p>Lei G-P, Liu Y-X, Sun Y, 2007, Characteristics of Deficiency-Reality Pathogenesis in Chronic Renal Failure and Treatment Ideas. Sichuan Traditional Chinese Medicine, 2007(11): 28-29.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B17" content-type="article"><label>17</label><element-citation publication-type="journal"><p>Dai J, (ed) 2002, Practical Chinese Medicine Nephrology, People’s Health Publishing House, Beijing, 122.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B18" content-type="article"><label>18</label><element-citation publication-type="journal"><p>Gong ZD, 2017, Treatment of Chronic Glomerulonephritis from the Lung Theory. Chinese Journal of Traditional Chinese Medicine Information, 24(11): 115-117.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B19" content-type="article"><label>19</label><element-citation publication-type="journal"><p>Bai E, Yan W, Li R, et al., 2020, Overview of Ancient and Modern Studies on the Diuretic and Anti-Swelling Effects of Astragalus Membranaceus. Journal of Shanxi University of Traditional Chinese Medicine, 21(06): 461-464. DOI: 10.19763/j.cnki.2096-7403.2020.06.21</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B20" content-type="article"><label>20</label><element-citation publication-type="journal"><p>Lei G-P, 2016, Discussion on the Chinese Medical Pathogenesis and Treatment of Primary Nephrotic Syndrome Membranous Nephropathy. Chinese Journal of Integrated Chinese and Western Medicine and Nephrology, 17(05): 443-445.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
